Health Catalyst HCAT 深 沪
交易中 07-07 10:42:04 美东时间
2.345
+0.055
+2.40%
华盛通- 最 高2.37
- 今 开2.29
- 成交量 27.95万股
- 最 低 2.25
- 昨 收 2.29
- 总市值 17.33万
- 52周最高 4.115
- 市盈率 静 --
- 换手率 0.38%
- 52周最低 0.9551
- 委 比 69.73%
- 总股本 7.39万
- 历史最高 59.50
- 量 比 1.47
- 振 幅 5.24%
- 历史最低 0.9551
- 每 手 1
- 风险率 0.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅90.66%！Tango Therapeutics获杰富瑞升目标价至60美元，上调至"买入"评级
今日重点评级关注：杰富瑞：上调Tango Therapeutics评级至"买入"，目标价从27美元升至60美元；Susquehanna：维持安森美半导体"积极"评级，目标价从120美元升至140美元
06-29 15:49
富国银行维持Health Catalyst持股观望评级 将目标价上调至1.75美元
富国银行分析师斯坦·贝伦施泰因对Health Catalyst维持“持股观望”评级，将其目标价从1美元上调至1.75美元。 译文内容由第三方软件翻译。 声明：市...
06-27 03:19
Wells Fargo Maintains Equal-Weight on Health Catalyst, Raises Price Target to $1.75
Wells Fargo analyst Stan Berenshteyn maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and raises the price target from $1 to $1.75.
06-27 03:06
Health Catalyst to Participate in Upcoming Investor Conference
Health Catalyst executives will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion on "AI ROI in Healthcare: Real vs Hype Debate" led by CEO Ben Albert on June 24, 2026. Health Catalyst is a healthcare intelligence company leveraging AI-driven technology to improve health system performance across cost, clinical, and consumer metrics.
06-16 20:05
美股牛股 | 蹭上SpaceX、登月概念！美国电池创业公司Solidion暴涨超350%；新股狂欢！SSMR上市涨超20%
蹭上SpaceX、登月概念！美国电池创业公司Solidion暴涨超350%；新股狂欢！SSMR、LFTO、INIO上市均涨超20%>>
06-05 18:45
Health Catalyst Agrees To Divest Vitalware And Vitalware Business Unit To Med-Metrix For Total Consideration Of $147M In Cash
Health Catalyst, Inc. (("Health Catalyst" or the "Company, NASDAQ:HCAT) today announced it has signed a definitive agreement to divest Vitalware, LLC and the Vitalware business unit, its mid-revenue cycle business, to
06-04 21:10
Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation
Health Catalyst has agreed to sell its Vitalware mid-revenue cycle business to Med-Metrix for $147 million in cash, allowing the company to focus on AI and core technologies. The transaction is expected to strengthen Health Catalyst's balance sheet and provide financial flexibility for strategic investments. Vitalware, a healthcare software provider, will benefit from Med-Metrix's resources in revenue cycle management. The deal is subject to regu...
06-04 13:03
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Health Catalyst Earnings Call Maps Costly Transition
Health Catalyst (($HCAT)) has held its Q1 earnings call. Read on for the main h...
05-13 08:27
Stephens & Co. Maintains Equal-Weight on Health Catalyst, Lowers Price Target to $1.75
Stephens & Co. analyst Jeff Garro maintains Health Catalyst (NASDAQ:HCAT) with a Equal-Weight and lowers the price target from $2 to $1.75.
05-12 21:35
